MB
LHDX

MPM BioImpact’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

MPM BioImpact’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-578,114
Closed -$4.39M – 34
2021
Q3 		$4.39M Buy
+578,114
New +$4.88M 0.68% 28

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return

MPM BioImpact's LHDX Position: Q4 2021 in Review

MPM BioImpact sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2021, closing a stake of 578,114 shares — an estimated $4.39M sold.

MPM BioImpact first reported a position in LHDX in Q3 2021 and held it in 1 quarter. The position peaked at $4.39M in Q3 2021. 46 funds tracked by Wall St. Rank hold LHDX as of Q4 2021.

  • MPM BioImpact reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • MPM BioImpact sold 578,114 Lucira Health, Inc. Common Stock shares in Q4 2021, an estimated $4.39M.
  • MPM BioImpact first reported a position in Lucira Health, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • MPM BioImpact's Lucira Health, Inc. Common Stock position peaked at $4.39M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2021.

Based on MPM BioImpact's 13F filing for Q4 2021, filed 11 Feb 2022.